Ticker
BFRICompany Name
BIOFRONTERA INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 20.14M | $ 7.24M | 35.94% |
3/31/2025 | $ 16.59M | $ 1.78M | 10.76% |
12/31/2024 | $ 22.1M | $ 5.91M | 26.72% |
9/30/2024 | $ 18.52M | $ 2.87M | 15.52% |
6/30/2024 | $ 21.57M | $ 4.38M | 20.3% |
3/31/2024 | $ 24.57M | $ 3.82M | 15.53% |
12/31/2023 | $ 27.93M | $ 1.34M | 4.81% |
9/30/2023 | $ 34.1M | $ 3.42M | 10.03% |
6/30/2023 | $ 36.91M | $ 4.45M | 12.07% |
3/31/2023 | $ 41.97M | $ 13.51M | 32.18% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for BIOFRONTERA INC is calculated as follows: CashnEq [ $ 3.05M ] / Assets [ $ 17.7M ]
(=) Cash to Assets [ 17.25% ]
Minimum
Dec 31, 2023
Maximum
Jun 30, 2022
Average
Median
filtered constituents | 3.94K |
---|---|
min | 0% |
max | 40.8% |
average | 9.79% |
median | 6.44% |
std | 9.55% |